ASCEND BY NTHRYS
Research Abroad Products

Cancer Systems Biology Project Topics

Browse all focused areas across all project categories under this field.

Showing 37–48 of 200 project topics
Temporal Clonal Evolution Biomarker Extraction
A machine learning pipeline that extracts predictive biomarkers from longitudinal clonal evolution data to forecast patient survival and treatment response. Monetizes through partnerships with diagnostic companies and integration into clinical decision-support platforms.
Tumor Evolution & Clonal Dynamics Modeling Click to view more details →
Treatment-Induced Clonal Architecture Analytics
Commercial analytics platform analyzing how chemotherapy, immunotherapy, and targeted drugs reshape clonal populations using pre- and post-treatment sequencing. Generates revenue by supporting adaptive trial designs and real-time treatment optimization in precision oncology clinics.
Tumor Evolution & Clonal Dynamics Modeling Click to view more details →
Metastatic Clonal Origin Identification System
Proprietary software that traces metastatic lesions back to primary tumor clones and models dissemination timing through phylogenetic inference. Delivers value to oncology centers for understanding disease progression and personalizes treatment planning with premium subscription tiers.
Tumor Evolution & Clonal Dynamics Modeling Click to view more details →
Clonal Fitness Prediction and Ranking API
RESTful API service that predicts relative fitness of tumor clones and ranks treatment vulnerabilities using integrated multi-omics models. Enables integration into third-party oncology software platforms and generates revenue through API usage fees and enterprise licensing.
Tumor Evolution & Clonal Dynamics Modeling Click to view more details →
SL-Predict: AI-Driven Synthetic Lethal Pair Discovery Platform
A machine learning platform that identifies novel synthetic lethal gene pairs by analyzing multi-omics cancer datasets and predicting drug-gene interaction vulnerabilities. Enables pharma companies to validate 10x more therapeutic targets annually, reducing preclinical screening costs by 40-60% and accelerating drug pipeline productivity.
Synthetic Lethality Network Analytics Platforms Click to view more details →
NetPath Analytics: Real-Time Synthetic Lethality Network Visualization SaaS
A cloud-based SaaS platform providing interactive network mapping of synthetic lethal dependencies across tumor genotypes with real-time data integration from genomic databases. Generates recurring subscription revenue while enabling biotech firms to design precision oncology trials 3-4 months faster with higher success rates.
Synthetic Lethality Network Analytics Platforms Click to view more details →
LethGenome: Clinical-Grade Synthetic Lethal Mutation Screening Software
Enterprise software that performs high-throughput screening of patient tumor genomes against curated synthetic lethal interaction databases to match patients with targeted combination therapies. Creates B2B2C revenue streams through hospital licensing agreements and companion diagnostic partnerships worth $500K-$2M annually per institution.
Synthetic Lethality Network Analytics Platforms Click to view more details →
ComboScore: Predictive Ranking Tool for Drug-Drug Synthetic Lethal Combinations
A computational scoring platform that ranks potential two-drug and three-drug combinations based on synthetic lethal network dependencies and patient-specific genomic profiles. Enables CROs to prioritize combination trials, reducing Phase II failure rates and generating licensing revenue from major pharmaceutical partners.
Synthetic Lethality Network Analytics Platforms Click to view more details →
VulnDB: Comprehensive Synthetic Lethality Target Intelligence Knowledge Repository
A curated, continuously-updated database integrating published synthetic lethal interactions, functional genomics data, and proprietary screening results with advanced search and filtering capabilities. Monetizes through tiered subscription models ($50K-$500K annually) serving biotech, pharma, and academic research institutions globally.
Synthetic Lethality Network Analytics Platforms Click to view more details →
PathogenomX: Multi-Cancer Synthetic Lethal Pathway Modeling and Simulation Platform
A digital platform enabling systems-level simulation of synthetic lethal networks across different cancer types using mechanistic pathway models and patient cohort data. Delivers commercial value through precision medicine consulting services and licensing to pharmaceutical companies developing indication-specific combination therapies.
Synthetic Lethality Network Analytics Platforms Click to view more details →
ResistanceMap: Acquired Resistance Prediction via Synthetic Lethality Network Dynamics
Software that models tumor evolution and predicts emergence of drug resistance by analyzing dynamic changes in synthetic lethal vulnerability landscapes during treatment. Supports clinical decision-making for adaptive therapy protocols and generates revenue through integration with hospital EMR systems and oncology decision support networks.
Synthetic Lethality Network Analytics Platforms Click to view more details →
SL-Partner: Collaborative Platform for Synthetic Lethality Drug Discovery Partnerships
A secure B2B collaboration platform where biotech companies, pharma firms, and contract research organizations share synthetic lethal screening data, validate targets, and co-develop combination therapeutics. Generates revenue through platform licensing fees, transaction fees on collaboration deals, and premium analytics services.
Synthetic Lethality Network Analytics Platforms Click to view more details →